286 related articles for article (PubMed ID: 32824813)
1. Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.
Charan M; Verma AK; Hussain S; Misri S; Mishra S; Majumder S; Ramaswamy B; Ahirwar D; Ganju RK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824813
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.
Kalla Singh S; Tan QW; Brito C; De León M; De León D
Growth Horm IGF Res; 2010 Jun; 20(3):245-54. PubMed ID: 20347606
[TBL] [Abstract][Full Text] [Related]
3. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.
Deshmukh SK; Srivastava SK; Tyagi N; Ahmad A; Singh AP; Ghadhban AAL; Dyess DL; Carter JE; Dugger K; Singh S
Carcinogenesis; 2017 Aug; 38(8):757-765. PubMed ID: 28430867
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic value of natural agents to treat miRNA targeted breast cancer in African-American and Caucasian-American women.
Rahman KM; Sakr WA
Curr Drug Targets; 2012 Dec; 13(14):1917-25. PubMed ID: 23140300
[TBL] [Abstract][Full Text] [Related]
6. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
Deshmukh SK; Srivastava SK; Bhardwaj A; Singh AP; Tyagi N; Marimuthu S; Dyess DL; Dal Zotto V; Carter JE; Singh S
Oncotarget; 2015 May; 6(13):11231-41. PubMed ID: 25868978
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.
Vidal G; Bursac Z; Miranda-Carboni G; White-Means S; Starlard-Davenport A
Cancer Med; 2017 Jul; 6(7):1776-1786. PubMed ID: 28612435
[TBL] [Abstract][Full Text] [Related]
8. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
[TBL] [Abstract][Full Text] [Related]
9. Serum Biomarkers for Racial Disparities in Breast Cancer Progression.
Srivastava M; Eidelman O; Craig J; Starr J; Kvecher L; Liu J; Hueman M; Pollard HB; Hu H; Shriver CD
Mil Med; 2019 Mar; 184(Suppl 1):652-657. PubMed ID: 30901475
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract][Full Text] [Related]
11. Health and Racial Disparity in Breast Cancer.
Yedjou CG; Sims JN; Miele L; Noubissi F; Lowe L; Fonseca DD; Alo RA; Payton M; Tchounwou PB
Adv Exp Med Biol; 2019; 1152():31-49. PubMed ID: 31456178
[TBL] [Abstract][Full Text] [Related]
12. Examining breast cancer disparities in African Americans with suggestions for policy.
Pellom ST; Arnold T; Williams M; Brown VL; Samuels AD
Cancer Causes Control; 2020 Sep; 31(9):795-800. PubMed ID: 32524509
[TBL] [Abstract][Full Text] [Related]
13. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and Posttranscriptional Modulation of SOS1 Can Promote Breast Cancer Metastasis through Obesity-Activated c-Met Signaling in African-American Women.
Xing F; Zhao D; Wu SY; Tyagi A; Wu K; Sharma S; Liu Y; Deshpande R; Wang Y; Cleary J; Miller LD; Chittiboyina AG; Yalamanchili C; Mo YY; Watabe K
Cancer Res; 2021 Jun; 81(11):3008-3021. PubMed ID: 33446575
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokine levels and breast cancer risk factors: racial differences of healthy Caucasian and African American women.
Park NJ; Kang DH
Oncol Nurs Forum; 2013 Sep; 40(5):490-500. PubMed ID: 23975184
[TBL] [Abstract][Full Text] [Related]
16. Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
Vallega KA; Liu N; Myers JS; Yu K; Sang QX
PLoS One; 2016; 11(6):e0157741. PubMed ID: 27314854
[TBL] [Abstract][Full Text] [Related]
17. The racial disparity in breast cancer mortality.
Whitman S; Ansell D; Orsi J; Francois T
J Community Health; 2011 Aug; 36(4):588-96. PubMed ID: 21190070
[TBL] [Abstract][Full Text] [Related]
18. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.
Palmer JR; Ambrosone CB; Olshan AF
Cancer Causes Control; 2014 Mar; 25(3):309-19. PubMed ID: 24343304
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.
Cunningham JE; Montero AJ; Garrett-Mayer E; Berkel HJ; Ely B
Cancer Causes Control; 2010 Mar; 21(3):399-409. PubMed ID: 20024610
[TBL] [Abstract][Full Text] [Related]
20. Race-associated biological differences among Luminal A breast tumors.
D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
